Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571)

Tumour lysis syndrome (TLS) is a rare side effect of chemotherapy for solid tumours. It describes the metabolic derangements following rapid and extensive tumour cell death following a good response to chemotherapy. Symptoms are those of metabolic derangement and renal failure. Treatment involves re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinder, Elizabeth M., Atwal, Gurprit S. S., Ayantunde, Abraham A., Khan, Sarah, Sokal, Mike, McCulloch, Tom, Parsons, Simon L.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225466/
https://www.ncbi.nlm.nih.gov/pubmed/18274611
http://dx.doi.org/10.1155/2007/82012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225466/
https://www.ncbi.nlm.nih.gov/pubmed/18274611
http://dx.doi.org/10.1155/2007/82012

Ejemplares similares